0

Ramatroban

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP116649855
CAS116649-85-5
Structure
MDL NumberMFCD00887606
Molecular Weight416.47
InChI KeyLDXDSHIEDAPSSA-OAHLLOKOSA-N
Description≥98% (HPLC), solid
SolubilityDMSO: ≥40 mg/mL; H2O: insoluble
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size5MG, 25MG
Storage Conditions2-8°C
1

[Ramatroban (Baynas): A Review of Its Pharmacological and Clinical Profile]

Y Motobayashi, W Imagawa, K Saida

Nihon Yakurigaku Zasshi. 2001 Dec;118(6):397-402.

PMID: 11778458

1

Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor

Raja Chakraborty, Rajinder P Bhullar, Shyamala Dakshinamurti, John Hwa, Prashen Chelikani

PLoS One. 2014 Jan 23;9(1):e85937.

PMID: 24465800

1

Ramatroban (BAY U 3405): A Novel Dual Antagonist of TXA2 Receptor and CRTh2, a Newly Identified Prostaglandin D2 Receptor

Toshiaki Ishizuka, Takemi Matsui, Yasuhiro Okamoto, Atsuko Ohta, Michitaka Shichijo

Cardiovasc Drug Rev. Summer 2004;22(2):71-90.

PMID: 15179446

1

Ramatroban, a TP Receptor Antagonist, Improves Vascular Responses to Acetylcholine in Hypercholesterolemic Rabbits in Vivo

Toshiaki Ishizuka, Takemi Matsui, Akira Kurita

Eur J Pharmacol. 2003 May 2;468(1):27-35.

PMID: 12729840

1

Targeting the PGD 2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives

Maciej Kupczyk, Piotr Kuna

Drugs. 2017 Aug;77(12):1281-1294.

PMID: 28612233

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode